Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - INNOVUS PHARMACEUTICALS, INC. | Financial_Report.xls |
| 10-K/A - FORM 10-K/A - INNOVUS PHARMACEUTICALS, INC. | v339283_10ka.htm |
| EX-31.1 - EXHIBIT 31.1 - INNOVUS PHARMACEUTICALS, INC. | v339283_ex31-1.htm |
EXHIBIT 32.1
Section 1350 Certification
In connection with the Annual Report of Innovus Pharmaceuticals, Inc. (the “Company”) on Form 10-K/A for the year ended December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bassam Damaj, principal executive officer and principal financial officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company. |
| March 27, 2013 | /s/Bassam Damaj | |
|
Bassam Damaj, President and Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) |